Topic: Mrna Patents

Dr. David Martin joins the program to discuss the classification of mRNA injections as gene therapy rather than vaccines. Martin, an expert in intangible asset finance and innovation, argues that the COVID-19 project was a premeditated biological warfare event. He highlights the role of major tech figures like Larry Ellison and Sam Altman in the ongoing push for AI-driven medical interventions.

The mRNA platform itself, rather than just the spike protein, is identified as a primary source of medical pathology. The platform allows pharmaceutical companies to quickly reformulate and re-patent vaccines, which is seen as a business-driven motivation for its normalization. Critics argue that the platform's inherent flaws make it unsuitable for broad public use.

Dr. Huff argues that SARS-CoV-2 was co-developed with its medical countermeasure, citing perfect genetic matches to sequences patented by Moderna and NIH years prior. He critiques the mRNA platform for failing to prevent transmission and instead driving the emergence of new variants. Huff explains his transition from being pro-vaccine to a critic after reviewing clinical trial reports and histopathology data.

Attorney Todd Callender's claims regarding the legal status of vaccinated individuals are discussed, suggesting that mRNA injections could technically change a person's genomic classification. The theory posits that patent holders of the synthetic mRNA could claim ownership over the "end product," potentially bypassing 13th Amendment protections against slavery. This is linked to Klaus Schwab's "Fourth Industrial Revolution" and the goal of merging biological and digital identities.

Dr. Roberts discusses claims that thousands of patents for the COVID-19 virus and vaccines existed years before the pandemic began. He suggests that the push for universal vaccination, despite known risks, points toward a population control program. The segment references Dr. Anthony Fauci and Peter Daszak in relation to the development of airborne SARS viruses at the Wuhan lab.